Cardiovascular adverse effect (includes major adverse cardiovascular events (MACE))
- (2026): Mu X+, Basic Clin Pharmacol Toxicol 138(6), e70242 [Review] (pharmacovigilance / pharmacoepidemiology)
- (2026): Qian B+, Cardiol Rev Apr, Online ahead of print [Review]
